Riskpilot← Back to searchSign inGet full accessKLINIK FOR FYSIOTERAPI V/BJARKE BILDE ApS
APSActiveCVR 13902372Dronning Margrethes Vej 26Physiotherapy activities · NACE 8695Est. 19902 employees
Revenue 2025
DKK 2,6M
+7% vs 2024
EBITDA margin
23.9%
+10% vs 2024
Equity ratio
82.4%
Financial strength
Net profit 2025
DKK 474K
+12% vs 2024
| Revenue | DKK 2,6M | +7% |
| EBITDA | DKK 621K | +10% |
| Net profit | DKK 474K | +12% |
| Total assets | DKK 1,8M | +9% |
| Equity | DKK 1,4M | +5% |
| Employees | 2 | — |
Legal name
KLINIK FOR FYSIOTERAPI V/BJARKE BILDE ApS
CVR number
13902372
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
1. februar 1990
Share capital
DKK 125.000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at drive fysioterapivirksomhed.
Address
Dronning Margrethes Vej 26
Phone
+4546373301
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3.222 | 2.741 | 6.036 | 2.421 | 2.599 |
| Staff expenses | -1.966 | -1.934 | -1.881 | -1.858 | -1.978 |
| EBITDA | 1.256 | 807 | 4.139 | 563 | 621 |
| Depreciation & amort. | -27 | -27 | -27 | -22 | -12 |
| EBIT | 1.230 | 781 | 4.112 | 541 | 608 |
| Net financials | -12 | -8 | -1 | 0 | -0 |
| Profit before tax | 1.218 | 773 | 4.111 | 541 | 608 |
| Tax | 269 | 171 | 905 | 119 | 134 |
| Net profit | 948 | 601 | 3.206 | 422 | 474 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2.545 | 1.962 | 5.265 | 1.610 | 1.751 |
| Equity | 1.940 | 1.541 | 4.147 | 1.369 | 1.444 |
| Long-term debt | 268 | 172 | 907 | 121 | 135 |
| Short-term debt | 334 | 247 | 210 | 120 | 173 |
| Total debt | 602 | 419 | 1.117 | 241 | 307 |
EBITDA margin
23.9%
This company
15.8%
Market median
+51% vs market
20212025
Equity ratio
82.4%
This company
38.2%
Market median
+116% vs market
20212025
Return on equity
32.8%
This company
18.4%
Market median
+78% vs market
20212025
Net profit margin
18.2%
This company
8.1%
Market median
+125% vs market
20212025
Asset turnover
1.48×
This company
1.12×
Market median
+32% vs market
20212025
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NS Management | Management | 1990 |
| Former (7) | ||
| Audit | 2007 – 2009 | |
OB Management | Management | 1990 – 1991 |
ET | Audit | 1990 – 1990 |
BY Management | Management | 1990 – 1992 |
EL Audit | Audit | 1990 – 2001 |
SS Management | Management | 1990 – 1990 |
SH | Audit | 2001 – 2003 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 1990 – 1990 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NSBB Holding ApS
KLINIK FOR FYSIOTERAPI V/BJARKE BILDE ApS Board members of KLINIK FOR FYSIOTERAPI V/BJARKE BILDE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| THEILL ANDERSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB | Audit | 0 companies |
| Ole Bæk | Management | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| Bent Yding Bilde | Management | 0 companies |
| Norman Skjold Bjarce Bilde | Management | 0 companies |
| Erling Leth | Audit | 0 companies |
| Susanne Saul Stakemann | Management | 0 companies |
| Søren Harmundal Petersen | Audit | 0 companies |
| Per Emil Hasselbalch Stakemann | Board of Directors | 0 companies |